Literature DB >> 15352138

A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.

Guk-Hee Suh1, Young-Su Ju, Byeong Kil Yeon, Ajit Shah.   

Abstract

OBJECTIVE: To measure rates of decline in cognition and function in patients with Alzheimer's disease (AD) and to investigate their accelerating risk factors in Korea.
METHODS: This study presents longitudinal data on a community-based sample of 107 patients with AD, followed at 6 months and 12 months. The cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog), the Mini Mental State Examination (MMSE) and the Disability Assessment for Dementia Scale (DAD) were given. Mixed model analyses were conducted using the following independent variables: times of repeated assessment (0, 6 or 12 months), severity of dementia assessed by the Functional Assessment Staging (FAST) and individual indicators as covariates.
RESULTS: Average annual rates of decline in the MMSE, the ADAS-cog and the DAD were 2.3, 11.4 and 15.1 points, respectively. Neither gender, duration of formal education, nor duration of AD since onset was significant predictors of cognitive and functional decline. Patterns of functional decline in total DAD, instrumental ADLs, planning and organization and performance subscale are linear as MMSE score declines, while those of the basic ADLs and the initiation are curvilinear.
CONCLUSION: This naturalistic observational study measured rates of cognitive and functional decline in AD, and can provide reference data for further longitudinal studies or clinical trials. Further study will be necessary to determine whether linear or curvilinear pattern in functional decline is due to progression of AD itself or statistical artifact.

Entities:  

Mesh:

Year:  2004        PMID: 15352138     DOI: 10.1002/gps.1168

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  39 in total

1.  The relationship between education level and mini-mental state examination domains among older Mexican Americans.

Authors:  Diana Matallana; Cecilia de Santacruz; Carlos Cano; Pablo Reyes; Rafael Samper-Ternent; Kyriakos S Markides; Kenneth J Ottenbacher; Carlos A Reyes-Ortiz
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-06-10       Impact factor: 2.680

2.  Relearning of Activities of Daily Living: A Comparison of the Effectiveness of Three Learning Methods in Patients with Dementia of the Alzheimer Type.

Authors:  J Bourgeois; M Laye; J Lemaire; E Leone; A Deudon; N Darmon; C Giaume; V Lafont; S Brinck-Jensen; A Dechamps; A König; P Robert
Journal:  J Nutr Health Aging       Date:  2016-01       Impact factor: 4.075

3.  Rapid cognitive decline in Alzheimer's disease. Consensus paper.

Authors:  M E Soto; S Andrieu; C Arbus; M Ceccaldi; P Couratier; T Dantoine; J-F Dartigues; S Gillette-Guyonnet; F Nourhashemi; P-J Ousset; M Poncet; F Portet; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

4.  Alzheimer's disease: rapid and slow progression.

Authors:  Craig J Thalhauser; Natalia L Komarova
Journal:  J R Soc Interface       Date:  2011-06-08       Impact factor: 4.118

5.  Upper and lower extremity motor performance and functional impairment in Alzheimer's disease.

Authors:  Liesi E Hebert; Julia L Bienias; Judith J McCann; Paul A Scherr; Robert S Wilson; Denis A Evans
Journal:  Am J Alzheimers Dis Other Demen       Date:  2010-05-19       Impact factor: 2.035

6.  Modeling of bounded outcome scores with data on the boundaries: application to disability assessment for dementia scores in Alzheimer's disease.

Authors:  Xu Steven Xu; Mahesh Samtani; Min Yuan; Partha Nandy
Journal:  AAPS J       Date:  2014-08-28       Impact factor: 4.009

Review 7.  Cognitive reserve and Alzheimer's disease.

Authors:  Wei Xu; Jin-Tai Yu; Meng-Shan Tan; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

8.  Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial.

Authors:  Samuel T Henderson; Janet L Vogel; Linda J Barr; Fiona Garvin; Julie J Jones; Lauren C Costantini
Journal:  Nutr Metab (Lond)       Date:  2009-08-10       Impact factor: 4.169

9.  The factorial structure of the Mini-Mental State Examination (MMSE) in Japanese dementia patients.

Authors:  Kenta Shigemori; Shohei Ohgi; Eriko Okuyama; Takaki Shimura; Eric Schneider
Journal:  BMC Geriatr       Date:  2010-06-09       Impact factor: 3.921

Review 10.  For whom and for what the definition of severe dementia is useful: an EDCON consensus.

Authors:  E J Byrne; M Benoit; J M Lopez Arrieta; C Geraldi; R Koopmans; Y Rolland; N Sartorius; G Stoppe; P Robert
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.